Veracyte | VCYT - Stock


Veracyte reported $22.66M in Stock for its fiscal quarter ending in June of 2026.





Stock Change Date
Agilent USD 1.09B 30M Mar/2026
Anika Therapeutics USD 28.56M 5.73M Jun/2026
Arrowhead Research USD -173.08M 173.08M Dec/2024
Bruker USD 1.12B 1.4M Jun/2026
Heron Therapeutics USD 54.57M 2.33M Dec/2022
Illumina USD 629M 18M Jun/2026
Intrexon USD 287K 68K Dec/2022
Karyopharm Therapeutics USD 4.04M 72K Dec/2025
Laboratory Of America USD 562.2M 64.5M Jun/2026
Ligand Pharmaceuticals USD 10.26M 3M Jun/2026
Myriad Genetics USD 30.6M 2.7M Jun/2026
Rigel Pharmaceuticals USD 13.3M 2.88M Sep/2025
Roche Holding CHF 7.6B 9M Jun/2025
Siemens EUR 11.5B 399M Mar/2026
Sonic Healthcare AUD 208.83M 3.83M Jun/2024
Thermo Fisher Scientific USD 5.5B 71M Mar/2026
Veracyte USD 22.66M 1.24M Jun/2026
Waters USD 1.38B 119M Jun/2026